DocGo Inc.
General ticker "DCGO" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $106.4M (TTM average)
DocGo Inc. does not follow the US Stock Market performance with the rate: -22.1%.
Estimated limits based on current volatility of 4.3%: low 0.37$, high 0.41$
Factors to consider:
- Total employees count: 3568 (-19.0%) as of 2025
- US accounted for 90.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Strategic risks and growth management, Acquisition/divestiture risks, Regulatory and compliance, IT system failures, Liquidity and credit risks
- Current price 35.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.63$, 1.71$]
- 2026-12-31 to 2027-12-31 estimated range: [0.66$, 1.74$]
Financial Metrics affecting the DCGO estimates:
- Positive: with PPE of -0.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 38.98 > 13.08
- Positive: Shareholder equity ratio, % of 66.33 > 63.63
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -9.15 < Industry operating profit margin (median), % of -0.34
Short-term DCGO quotes
Long-term DCGO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $624.29MM | $616.56MM | $322.20MM |
| Operating Expenses | $609.23MM | $587.87MM | $500.20MM |
| Operating Income | $15.05MM | $28.69MM | $-178.00MM |
| Non-Operating Income | $1.24MM | $-0.94MM | $-9.50MM |
| R&D Expense | $10.86MM | $11.59MM | $13.56MM |
| Income(Loss) | $16.29MM | $27.75MM | $-187.50MM |
| Taxes | $6.24MM | $14.39MM | $-8.90MM |
| Net Income(Loss)* | $6.86MM | $19.99MM | $-182.40MM |
| Stockholders Equity | $300.79MM | $320.92MM | $144.01MM |
| Assets | $490.45MM | $455.62MM | $217.10MM |
| Operating Cash Flow | $-64.22MM | $70.34MM | $34.45MM |
| Capital expenditure | $10.13MM | $5.84MM | $7.43MM |
| Investing Cash Flow | $-29.88MM | $-10.87MM | $-39.08MM |
| Financing Cash Flow | $1.12MM | $-24.15MM | $-50.82MM |
| Earnings Per Share** | $0.07 | $0.20 | $-1.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.